StockDriftsStockDriftsTop 2 Abg-Wtt Global Life Science Capital Partners Gp LTD Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| CBLL | CERIBELL INC | 62.61% | 275.3K | $5.4M | -37.68%(-166.49K) | $25.88(-9.85%) | 2026-06-30 | |
| RPID | RAPID MICRO BIOSYSTEMS INC | 37.39% | 1.85M | $3.2M | +0.00%(+0) | $5.67(-70.38%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | -7.99% | -22.12% | -56.16% | -98.38% |
| Top 20 Holdings Unweighted | -4.99% | -14.24% | -40.48% | -92.53% |
Abg-Wtt Global Life Science Capital Partners Gp LTD reports $8.55M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are CBLL (62.6%) and RPID (37.4%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -22.12% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Abg-Wtt Global Life Science Capital Partners Gp LTD, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Abg-Wtt Global Life Science Capital Partners Gp LTD’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1832108). View Abg-Wtt Global Life Science Capital Partners Gp LTD’s 13F filings on SEC